Akebia Therapeutics
AKBA
#7040
Rank
S$0.53 B
Marketcap
$2.45
Share price
1.68%
Change (1 day)
85.06%
Change (1 year)

P/S ratio for Akebia Therapeutics (AKBA)

P/S ratio as of November 2024 (TTM): 2.28

According to Akebia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -11.8. At the end of 2024 the company had a P/S ratio of 1.23.

P/S ratio history for Akebia Therapeutics from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.232.07%
20231.20230.14%
20220.3636-80.36%
20211.8535.09%
20201.37-40.3%
20192.30-26.23%
20183.11-21.21%
20173.95-98.48%
2016260
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.79 110.48%๐Ÿ‡บ๐Ÿ‡ธ USA
4.16 82.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
4.27 87.60%๐Ÿ‡บ๐Ÿ‡ธ USA
2.00-12.12%๐Ÿ‡บ๐Ÿ‡ธ USA